Logo image of EXOZ

EXOZYMES INC (EXOZ) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:EXOZ - US4618741098 - Common Stock

12.47 USD
+0.08 (+0.65%)
Last: 12/24/2025, 1:30:02 PM

EXOZ Key Statistics, Chart & Performance

Key Statistics
Market Cap104.62M
Revenue(TTM)N/A
Net Income(TTM)-8.34M
Shares8.39M
Float2.37M
52 Week HighN/A
52 Week LowN/A
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-1.76
PEN/A
Fwd PEN/A
Earnings (Next)03-31 2026-03-31
IPO2024-11-13
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


EXOZ short term performance overview.The bars show the price performance of EXOZ in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 20 -20

EXOZ long term performance overview.The bars show the price performance of EXOZ in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of EXOZ is 12.47 USD. In the past month the price decreased by -22.06%.

EXOZYMES INC / EXOZ Daily stock chart

EXOZ Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 24.33 406.30B
AMGN AMGEN INC 15.27 179.83B
GILD GILEAD SCIENCES INC 15.34 155.92B
VRTX VERTEX PHARMACEUTICALS INC 26.67 117.47B
REGN REGENERON PHARMACEUTICALS 17.41 82.37B
ALNY ALNYLAM PHARMACEUTICALS INC 785.67 52.94B
INSM INSMED INC N/A 37.84B
NTRA NATERA INC N/A 32.51B
BIIB BIOGEN INC 10.53 25.87B
UTHR UNITED THERAPEUTICS CORP 19.5 22.16B
INCY INCYTE CORP 15.64 19.72B
EXAS EXACT SCIENCES CORP N/A 19.27B

About EXOZ

Company Profile

EXOZ logo image eXoZymes, Inc. is a development stage synthetic biochemical company. The company is headquartered in Monrovia California, California and currently employs 31 full-time employees. The company went IPO on 2024-11-13. The firm has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.

Company Info

EXOZYMES INC

750 Royal Oaks Dr

Monrovia California CALIFORNIA US

Employees: 31

EXOZ Company Website

Phone: 16264151488

EXOZYMES INC / EXOZ FAQ

What does EXOZYMES INC do?

eXoZymes, Inc. is a development stage synthetic biochemical company. The company is headquartered in Monrovia California, California and currently employs 31 full-time employees. The company went IPO on 2024-11-13. The firm has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.


Can you provide the latest stock price for EXOZYMES INC?

The current stock price of EXOZ is 12.47 USD. The price increased by 0.65% in the last trading session.


Does EXOZ stock pay dividends?

EXOZ does not pay a dividend.


What is the ChartMill technical and fundamental rating of EXOZ stock?

EXOZ has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


How is the valuation of EXOZYMES INC (EXOZ) based on its PE ratio?

EXOZYMES INC (EXOZ) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.76).


When does EXOZYMES INC (EXOZ) report earnings?

EXOZYMES INC (EXOZ) will report earnings on 2026-03-31.


Can you provide the ownership details for EXOZ stock?

You can find the ownership structure of EXOZYMES INC (EXOZ) on the Ownership tab.


EXOZ Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

EXOZ Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to EXOZ. The financial health of EXOZ is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

EXOZ Financial Highlights

Over the last trailing twelve months EXOZ reported a non-GAAP Earnings per Share(EPS) of -1.76. The EPS decreased by -256.1% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -108.04%
ROE -155.17%
Debt/Equity 0.01
Chartmill High Growth Momentum
EPS Q2Q%-33.81%
Sales Q2Q%N/A
EPS 1Y (TTM)-256.1%
Revenue 1Y (TTM)N/A

EXOZ Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

EXOZ Ownership

Ownership
Inst Owners0.71%
Ins Owners24.86%
Short Float %0.45%
Short Ratio4.58